France urged it’s citizen not to use Moderna vaccine

French health authorities have advised people under the age of 30 not to use the Moderna Covid-19 vaccine. It comes after a research confirmed there was a slight risk of heart inflammation associated with the mRNA-based vaccine.

The study from Epi-Phare, an independent drug safety research group in collaboration with the French government, confirms previous findings.

They studied all people in France aged between 12 to 50 who were hospitalized for myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the tissue around the heart) between May 15th and August 31st, 2021.

The results showed that mRNA-based vaccines from Pfizer and Moderna have increased the risk of this disease within seven days of vaccination.

The low risk however, was higher in men under 30 years of age and especially after the second dose of the Moderna vaccine. According to research, this vaccine may be responsible for about 132 cases of myocarditis per million doses administered.

In the other hand, the result for Pfizer were almost 80% lower, with an estimated number of 27 cases per million doses.

While in women under 30 years, Moderna may cause 37 cases of myocarditis per million doses. The risk of pericarditis was also greater after a second dose of Moderna in people under 30 years of age, with 18 cases per million doses given in young men.

However, there were no deaths among hospitalized patients with the disease after vaccination.

In addition to France, the US authorities also delaying approval of Moderna injections for young people, although last week they recommended the use of the Pfizer vaccine for children ages 5 to 11 after reviewing the risk of myocarditis.

Pediatric cardiologist Matthew Oster said he was “much more concerned” about the risks of Covid to young people than the risks posed by vaccines.

Mahmoud Zureik, who heads Epi-Phare, echoed the sentiment. “When you measure the effectiveness of a vaccine against severe cases of Covid-19 against the risks that exist but are rare, the value of the vaccine is unquestionable,” he told AFP.

Leave a Reply